Researchers flag possible blood test for Alzheimer’s disease

Proudly supported by

  Last updated February 2, 2018 at 10:00 am

Topics:  

Breakthrough diagnostics could be a game-changer in the treatment of Alzheimer’s.



An Australian-Japanese research team has used the protein, amyloid-β, which is already associated with Alzheimer’s disease, as a marker to develop a test that predicts people at risk of developing Alzheimer’s disease with an accuracy greater than 90 per cent.


Amyloid-ß is a protein that is currently the best marker we have that correlates with the development of Alzheimer’s disease. These proteins build up and form plaques on the brains of people with Alzheimer’s disease.


“The presence of amyloid-β in the brain is one of the first signs that something is going awry, so to be able to identify changes using a blood test, which is easy and affordable, could make a big difference to whether we can use a preventative approach in treating Alzheimer’s disease,” said Dr Estella Newcombe, an Alzheimer’s disease researcher at Queensland Brain Institute.


“It accumulates before we see any cognitive decline or other protein abnormalities.”


Taking a new approach to testing for Alzheimer’s disease


The study involved an initial discovery data set in Japan with 121 people. This method was then validated by an Australian team with 252 people. This approach alone may soon become the gold standard for developing diagnostic tests, using an independent site to validate data and strengthen the validity of the study.


Data sets included a balanced number of individuals classified as cognitively normal, individuals with mild cognitive impairment, and individuals clinically diagnosed with Alzheimer’s disease with dementia.


“Nakamura and colleagues have taken plasma samples [derived from blood] from patients with Alzheimer’s disease or mild cognitive impairment and enriched these samples for one of the proteins responsible for Alzheimer’s disease: amyloid-β. Amyloid-β results from problematic enzymatic cleavage of the amyloid precursor protein, which we all have,” summarises Dr Newcombe.


“The success of this study comes from using the amyloid precursor protein as a reference in identifying the ratio of problematic amyloid-β. By using this ratio, the researchers have reduced a significant amount of variability between individuals, leading to better reproducibility in this diagnostic tool.”


This ratio could then be used predict the level of amyloid-beta build up on a patient’s brain.


The test itself was developed by Dr Koichi Tanaka, a 2002 Nobel Prize for Chemistry winner and expert on mass spectrometry.


Improvements for Alzheimer’s disease detection


“One of the worst things about Alzheimer’s disease is that by the time you realise you have it, a lot of the damage has been done. We lack tests for Alzheimer’s disease that are cheap and reliable enough that they can be used as a pre-emptive diagnostic test; one that might mean a person is diagnosed before they suffer too much of the significant neuronal loss associated with the disease,” explains Dr Newcombe.


Towards a blood test for Alzheimer’s disease. Credit: National Center for Geriatrics and Gerontology, Japan.


Currently detection methods are costly and inconvenient. In PET scans, trackable molecules are injected intravenously. They travel throutgh the blood to the brain and attach to amyloid plaques. The other method is extremely invasive, by assessing protein levels via lumbar puncture which takes the cerebrospinal fluid out from the spine.


“Nakamura and colleagues showed high reproducibility compared to PET scans, via a much easier and cheaper technique, making this plasma biomarker clinically promising. However, further international testing would be ideal, with sample collection being standardised,” said Dr Newcombe.


One of the authors of the paper, Professor Colin Masters, from the Florey Institute of Neuroscience and Mental Health, says that with earlier detection, it should lead to better outcomes for therapeutic success.


The revolutionary benefits of a biomarker diagnosis for Alzheimer’s disease


Currently, the test is only available for research-related purposes, meaning that in the more immediate future, it’s likely that this biomarker will be used for screening potential subjects for clinical trials for Alzheimer’s disease experimental treatments.


This biomarker holds a lot of potential, particularly in “screening for participants for clinical trials, particularly in the pre-clinical phases,” points out Prof Masters.


Due to the accuracy of the test, when people are cognitively normal, or have mild cognitive impairments, they will be able to know if potential subjects are on an Alzheimer’s disease pathway and thus their eligibility for a potential Alzheimer’s disease study.


Prof Masters also lists other benefits:



  • Potential for population screening for public health

  • Differential diagnoses – distinguishing different types of dementia in Alzheimer’s disease

  • Prognostic implications – tests may contain info about how fast a person may deteriorate

  • Monitoring the efficacy of any intervention, especially ones that are targeted at clearing the abnormal protein from the brain

  • Future therapies – improve cost and efficacy of clinical trials for pharmaceutical companies with fast and cheaper diagnoses


This breakthrough biomarker test is a real achievement for Prof Masters, who calls it “a 30-year odyssey”. At the Florey Institute, they have been working since 1989, nearly 30 years, on the potential for a blood test for Alzheimer’s disease. Hard work has paid off, he says “we can finally say we have a high-performing blood test.”


This research was published in Nature.


Alzheimer’s disease research remains a difficult, but not impossible, task


Earlier this month, a separate research paper reported the failings of a then-promising large clinical trial in the US. The drug, solanezumab, a monoclonal antibody-based treatment for Alzheimer’s disease developed by Eli Lilly targeted amyloid plaques, but it failed to significantly slow cognitive decline.


It was the first major Alzheimer’s clinical trial to require molecular evidence of amyloid deposition in the brain for enrollment.


In commentary on this recent study, Prof Masters explained that unfortunately the drug’s “efficacy wasn’t great enough to be registered [as a success]. It showed some degree of separation between [the] treatment group and placebo group, but it wasn’t large enough.”


He says that there is still potential for this promising drug. There are plans, involving Melbourne researchers, for a future multi-centre international clinical trial with the same drug but at a higher dose and extending the length of the US study, which only ran for 18 months.


This US research was published in the New England Journal of Medicine.


Related


Science update: Alzheimer’s Disease and other types of dementia


Brain gains – How exercise improves your brain


The Check Up – The Ethics of Brains, a Human Atlas, and Bees


Follow us on FacebookTwitter and Instagram to get all the latest science.




About the Author

Kelly Wong
Online producer at Australia's Science Channel. I have a background in immunology, food blogging, volunteering, and social media. I'm passionate about creating communities on social media and getting them excited about science. I enjoy good food and I am on an eternal mission to find the best ice cream. Find me on Twitter @kellyyyllek

Published By

Science and technology is as much a part of our cultural fabric as art, music, theatre and literature. They play a significant role in our daily lives, yet, in a world dependent on science, we often take them for granted. Australia’s Science Channel believes every citizen has a right, and a responsibility, to be informed, and our mission is to create programs to bring that about.


Featured Videos

Placeholder
The Face of a Stranger
Placeholder
Where Does Space Begin?
Placeholder
The Rarest Drug on Earth
Placeholder
Why is blue so rare in nature
Placeholder
Ant Sisters
Placeholder
Jeremy the Lefty Snail and Other Asymmetrical Animals
Placeholder
Tracking Snow
Placeholder
Smart Slime?
Placeholder
Good in the machine
Placeholder
Kessler Syndrome: What happens when satellites collide?
Placeholder
Why This Skateboarding Trick Should Be Impossible
Placeholder
Charles Camarda on becoming an astronaut
Placeholder
Alan Duffy on what it took to get humans to the Moon
Placeholder
Do aliens exist? Brian Cox explains
Placeholder
From Apollo to Pulsars: Parkes still dishing out the discoveries
Placeholder
Brian Cox on black holes
Placeholder
Australia's 60,000 years of space history
Placeholder
In Class With… Jane Goodall
Placeholder
Etienne Rastoin-Laplane - What's fishy about the Galapagos?
Placeholder
Kit Prendergast - Flowers to keep native bees buzzing
Placeholder
Rebecca Wellard - Eavesdropping on killer whales
Placeholder
Hossein Tavassoli - Mending broken hearts
Placeholder
Dilan Seckiner - Forensic gait analysis
Placeholder
Samuel Bladwell - A new spin on electronics
Placeholder
Sathana Dushyanthen - The double-edged cancer sword
Placeholder
Dwan Price - Nuts and Guts
Placeholder
Catriona Nguyen-Robertson - Exercise takes your immune system for a ride
Placeholder
Thimo Ruethers - The deadly danger of crocs on a plate
Placeholder
Amanda Tauber - Slamming the brakes on metastatic cancer
Placeholder
Hayley Teasdale – The ball that prevents falls (FameLab Australia 2019 Runner-up)
Placeholder
In the Shadow of a Black Hole
Placeholder
In Class With... Monica Gagliano
Placeholder
In Class With... Brian Cox
Placeholder
Start your FameLab 2019 journey now
Placeholder
Nural Cokcetin - It all starts with FameLab
Placeholder
Erinn Fagan-Jeffries - It all starts with FameLab
Placeholder
Ronald Yu - It all starts with FameLab
Placeholder
Noushin Nasiri - It all starts with FameLab
Placeholder
Grassroots
Placeholder
What is machine learning?
Placeholder
Mythbusting artificial intelligence with expert Anton van den Hengel
Placeholder
Using machine learning to predict medical outcomes
Placeholder
KCLOC
Placeholder
Nature Calls
Placeholder
Mexican Fishing Bats
Placeholder
Bittersweet
Placeholder
Timelapse
Placeholder
Invisible Blanket
Placeholder
Look
Placeholder
The Anomalies: Venom Race
Placeholder
Science Meets Making
Placeholder
Spiral
Placeholder
Looking Out There
Placeholder
Protectors of the Penguins
Placeholder
Astroturf
Placeholder
Virtual Humans
Placeholder
Rancheros del Jaguar
Placeholder
Searching For Dark Matter
Placeholder
Finding prehistoric mega-shark fossils on Victoria's coast
Placeholder
The Grandfather of computers
Placeholder
James Cameron talks science
Placeholder
In Class With.....David Suzuki - The Environment
Placeholder
In Class With.....David Suzuki - Career
Placeholder
Sustainable water use with Doug Green
Placeholder
Why is Indigenous science important?
Placeholder
Vanessa Pirotta - Using drones to collect whale snot (FameLab Australia 2018 Winner)
Placeholder
Toby Hendy - Poking Plants (FameLab Australia 2018 Runner-Up)
Placeholder
Muthu Vignesh Vellayappan - Groovy Patches (FameLab Australia 2018 Audience Choice)
Placeholder
Taryn Laubenstein - The Tail of Two Fishes
Placeholder
Richard Charlesworth - Coeliac disease diagnosis can be a pain in the posterior
Placeholder
Pegah Maasoumi - Solar Windows
Placeholder
James Wong - Breathing while you hop: How do kangaroos do it?
Placeholder
Ben McAllister - The ORGAN Experiment: Shining a light on dark matter
Placeholder
Mortaza Rezae - Empowering beautiful minds
Placeholder
Zane Stromberga - Can allergy drugs beat bladder disease?
Placeholder
Working In.....Art - Astrophotography
Placeholder
What's the best way to move - springs or muscles?
Placeholder
FameLab Australia Semi-Final Highlights
Placeholder
Saving lives with platypus milk
Placeholder
Australian astronomers witness death throes of a cocooned star
Placeholder
How Australia's politicians see our future in space
Placeholder
Keeping satellites in the loop
Placeholder
Tim Flannery talks about COP
Placeholder
Tim Jarvis & Tim Flannery talk Climate Change
Placeholder
Andy's Week in Science - robo baby, university rankings, and cancer on circadian rhythms
Placeholder
From chocolate factory to surgery - the milliDelta robot
Placeholder
Andy's Week in Science: video games, low tech transition windows and a new CRISPR technique
Placeholder
Science lessons useful in Art Restoration career
Placeholder
Are drones the future of racing?
Placeholder
The future of esports according to the experts
Placeholder
Seeing is believing with artist Eugenie Lee
Placeholder
The human impact of Art Science collaboration
Placeholder
Follow your Interests in Robotics
Placeholder
Zoz on 3D Printing
Placeholder
Flavia Tata Nardini on women in engineering
Placeholder
Flavia Tata Nardini on the future of the internet
Placeholder
Explore the ocean floor and Antarctic biodiversity
Placeholder
Follow your interests in Medical Research
Placeholder
Artists on Science
Placeholder
What is Space Archaeology?
Placeholder
Follow your Interests
Placeholder
Scientists on Art
Placeholder
3D Printing in Medical Research
Placeholder
Ethical Issues
Placeholder
Problem Solving - Robotics at Dermatec
Placeholder
Problem Solving with CSI
Placeholder
Tamarah King - Earthquake Geologist
Placeholder
True or False with Bajo and Rad BONUS ROUND
Placeholder
True or False with Bajo & Rad
Placeholder
Andy's Week in Science - Cats vs Dogs
Placeholder
FameLab 2018 - Get Involved!
Placeholder
Nural Cokcetin - How FameLab changed my life
Placeholder
Erinn Fagan-Jeffries - How FameLab changed my life
Placeholder
Noushin Nasiri - How FameLab changed my life
Placeholder
Ronald Yu - How FameLab changed my life
Placeholder
Alan Duffy's Top 5 Science Communication Tips
Placeholder
A Judge's Top Tips for FameLab Australia
Placeholder
Brain Candy - Why, Why, Why Michael Stevens?
Placeholder
The Past, Present, and Future of Malaria
Placeholder
This is a video of poo pills being made!
Placeholder
Mind Games - Sports Psychology
Placeholder
Fuel to Win - Sports Nutrition
Placeholder
Fifty years since Australia beat the world to space
Placeholder
ECR Network: Talk Your Science with Alan Duffy
Placeholder
Andy's Week in Science - chimps, klompen, and clouds
Placeholder
Our robot medicine future - heart huggers and micro biohybrids
Placeholder
Six Awkward Cancer Questions
Placeholder
How do you tell if a whale is left-handed?
Placeholder
She Flies - Turning Girls into Drone Pilots
Placeholder
Andy's Week in Science - Magnetic Fabric, Cancer Treatments, and Echolocation
Placeholder
The Science of Sexuality
Placeholder
Sailing Through Space with Bill Nye
Placeholder
Using Sports Science to Help Olympic Athletes
Placeholder
Three and a Half Minutes of Top Shelf Career Advice
Placeholder
New Space Tech with Andrea Boyd
Placeholder
Kelly Meets the Mars Curiosity Rover
Placeholder
Hearts, Opera, and Tough Conversations - Andy's Week in Science
Placeholder
Bill Nye on Science, Girls, and Saving the World!
Placeholder
2017 Prime Minister's Prizes for Science Part 2
Placeholder
2017 Prime Minister's Prizes for Science Part 1
Placeholder
Who Decides the Law in Space?
Placeholder
Scientists Watch Collision That Created Gravitational Waves
Placeholder
Getting Cold Feet Leads to a Whole New Career
Placeholder
ECR Network - Why Every Scientist Should Be on Twitter - The Benefits
Placeholder
ECR Network - Why Every Scientist Should Be On Twitter - The Fears
Placeholder
Live Podcast - Life Vs Science
Placeholder
Origami Robots, Babies, and Kidneys - Andy's Week in Science
Placeholder
Namira Salim and the Zero-G Peace Summit
Placeholder
Elon Musk's Mars Plan: Expert Analysis
Placeholder
SPACE AF - Thursday
Placeholder
My Time in Space
Placeholder
IAC TV Daily Broadcast - Wednesday
Placeholder
SPACE AF - Wednesday
Placeholder
IAC TV Daily broadcast - Tuesday
Placeholder
SPACE AF - Tuesday
Placeholder
IAC TV daily broadcast - Monday
01:00:41
Placeholder
SPACE AF - Monday
Placeholder
Live from IAC 2017
Placeholder
Brew Ha Ha - Technology Rewrites History
Placeholder
Methamphetamine - Gateway Drug to Parkinson's Disease
Placeholder
Concussion, 3D BioPrinting, and The Universe - Andy's Week in Science
Placeholder
Pulsars, Clearwigs, and Pacemakers - Andy's Week in Science
Placeholder
Revolutions - The Quest to Transform HPV Racing
Placeholder
Brew Ha Ha - Hurricane Irma Blows Away Tesla's Rip Off
Placeholder
Brew Ha Ha - The Limit of Your Lifespan
Placeholder
The Recipient
Placeholder
Think Like a Scientist: Natural Selection in an Outbreak
Placeholder
The End of Snow
Placeholder
The Next Rembrandt
Placeholder
The Discarded
Placeholder
The Spectators
Placeholder
Test Tube Babes
Placeholder
Pangolins in Peril- A Story of Rare Scales
Placeholder
Rock Art Project
Placeholder
Pork.0
Placeholder
OWSIA (Darkened Water)
Placeholder
Nex
Placeholder
Northern Quolls
Placeholder
Dish Life
Placeholder
At Street Level
Placeholder
Custom Love
Placeholder
Adrift
Placeholder
A Story from Space
Placeholder
Brew Ha Ha - The Most Dangerous Thing in Boxing May Be the Gloves
Placeholder
ECR Network 2017 – Get Interdisciplinary!
01:27:00
Placeholder
Chris Hadfield: The Future of Space Exploration
Placeholder
Chris Hadfield: Life After Space
Placeholder
Chris Hadfield: Life in Space
Placeholder
Brew Ha Ha - Let's Make Algae Australian of the Year
Placeholder
Brew Ha Ha - Australia's Energy Showdown
Placeholder
Nine Awkward Astrophysicist Questions
Placeholder
Brew Ha Ha - There's No Such Thing as an Exercise Pill
Placeholder
National Science Week Awards Show
Placeholder
Brew Ha Ha - Your 5 Step Asteroid Success Plan
Placeholder
National Science Week Forecast
Placeholder
Open Doors. Open Future. Open Day.
Placeholder
Brew Ha Ha - Lose a Little to Gain Millions
Placeholder
Brew Ha Ha - Crowd Sourcing Origami Astronaut Protection
Placeholder
Brew Ha Ha - T-Rex's Prehistoric Power Walk
Placeholder
True or False with Kale Brock
Placeholder
The Grandfather Paradox
Placeholder
Brew Ha Ha - The Hidden Heroes Tackling Mozzies
Placeholder
Brew Ha Ha - Emergency AI Assistance
Placeholder
Brew Ha Ha - Frogs Forever, Dinosaurs Never!
Placeholder
Brew Ha Ha - Australia, Let's Go To Space
Placeholder
Brew Ha Ha - Welcome to the Microbiome, Archaea!
Placeholder
Brew Ha Ha - Roos Blindside Driverless Cars
Placeholder
Biodiversity of Antarctica Under Threat From Increase In Ice-Free Areas
Placeholder
Brew Ha Ha - The Future of the Census
Placeholder
Tell Me! Brian Cox
Placeholder
Crash, Burn, Tweak, Repeat
Placeholder
Brew Ha Ha - Humans Just Got Older and Wiser
Placeholder
Brew Ha Ha - Cheers to Brain Health?
Placeholder
Gene Therapy Could Cure Allergies
Placeholder
Brew Ha Ha - iHeart Hacking
Placeholder
Ridiculology - New Hubble
Placeholder
Brew Ha Ha - Trees Alone Can't Save Us
Placeholder
Brew Ha Ha - Earth's Accidental Force Field
Placeholder
Dinosaurs on the Big Screen
Placeholder
Brew Ha Ha - Farewell MP3
Placeholder
Kids Beat Grown-ups on Pneumonia Vaccines
Placeholder
Brew Ha Ha - The Booger Conspiracy
Placeholder
FameLab 2017 National Final - Part 2
Placeholder
FameLab 2017 National Final - Part 1
Placeholder
2017 Budget Response
Placeholder
What Are Animal Weapons?
Placeholder
If You Love Both Art and Science, Be a Scientific Illustrator
Placeholder
Getting Personal With Skinks
Placeholder
Brew Ha Ha - CSIRO Email Leaks
Placeholder
FameLab 2017 Western Australia Semi-Final Highlights
Placeholder
Brew Ha Ha - New Hope for Premmies
Placeholder
Brew Ha Ha - Britain Goes Coal-Free
Placeholder
Brew Ha Ha - Naked Mole-Rats (SFW)
Placeholder
Brew Ha Ha - Easter Reminders
Placeholder
Meet Andrea Boyd - Space Flight Controller
Placeholder
Brew Ha Ha - Sperm Drug Smugglers
Placeholder
FameLab 2017 New South Wales Semi-Final Highlights
Placeholder
The Science of Fiction
Placeholder
Brew Ha Ha - Liquorice Poisoning
Placeholder
Brew Ha Ha - Crowdsourcing Science
Placeholder
FameLab 2017 Queensland Semi-Final Highlights
Placeholder
Brew Ha Ha - SpaceX Preps for Relaunch
Placeholder
Poly Cystic Ovary Syndrome Breakthrough
Placeholder
Brew Ha Ha - Surviving a Media Storm
Placeholder
Will This Aussie Team Win the Race to Create the Ultimate Malaria Vaccine?
Placeholder
Brew Ha Ha - New Dino Family Tree
Placeholder
How to fix things with Kyle Wiens
Placeholder
Repair or replace? iFixit co-founder Kyle Wiens
Placeholder
Special Investigation - No Alternative to Cancer
Placeholder
Brew Ha Ha - Raspberry Pi is Number 3 Best-Selling Computer